跳至主要内容
临床试验/NCT05854875
NCT05854875已完成不适用

RYGBP vs RYGBP With Fundus Resection for Morbid Obese Patients With Type 2 Diabetes. Evaluation of the Gastric Fundus in Glycemic Control. A Randomized Clinical Trial.

University of Patras1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2019年9月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
1
主要终点
Change in insulin levels, fasting and postprandial

研究概览

简要总结

The goal of this randomized clinical trial is to evaluate glycemic control in patients with morbid obesity and type 2 diabetes after Roux-en-Y gastric bypass (RYGBP) and RYGBP with fundus resection. The main questions to answer are:

  • Rate of diabetes remission and the role of the gastrointestinal hormones
  • Whether fundus resection leads to improved glycemic control

Patients will randomly undergo typical RYGBP or RYGBP with fundus resection. Gastrointestinal hormones profile [ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), glucagon], glucose levels and insulin response will be measured preoperatively, at 6 months and at 12 months, during 120-min OGTT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •morbid obesity (ΒΜΙ ≥ 40)
  • •type II diabetes mellitus (T2DM)
  • •duration of T2DM shorter than 8 years

排除标准

  • •pregnancy
  • •type 1 diabetes
  • •previous gastrointestinal surgeries
  • •alcohol consumption
  • •depression
  • •no compliance

研究组 & 干预措施

RYGBP

Active Comparator

Laparoscopic Roux en Y Gastric Bypass

干预措施: Laparoscopic Roux en Y gastric bypass (Procedure)

RYGBP + FR

Experimental

Laparoscopic Roux en Y Gastric Bypass with fundus resection

干预措施: Laparoscopic Roux en Y gastric bypass with fundus resection (Procedure)

结局指标

主要结局

Change in insulin levels, fasting and postprandial

时间窗: At 6 months and 12 months postoperatively

Insulin levels (μIU/ml)

Diabetes remission in both groups

时间窗: At 6 months and 12 months postoperatively

Change in HbA1c levels

Change in fasting and postprandial glucose levels

时间窗: At 6 months and 12 months postoperatively

Glucose levels (mg/dl)

Change in HOMA - IR

时间窗: At 6 months and 12 months postoperatively

HOMA IR calculation with glucose (mg/dl) and insulin (mU/L)

Change in ghrelin levels

时间窗: At 6 months and 12 months postoperatively

Fasting and postprandial ghrelin levels (pg/ml)

Change in GLP-1 levels

时间窗: At 6 months and 12 months postoperatively

Fasting and postprandial GLP-1 levels (pg/ml)

Change in PYY levels

时间窗: At 6 months and 12 months postoperatively

Fasting and postprandial PYY levels (ng/ml)

Change in glucagon levels

时间窗: At 6 months and 12 months postoperatively

Fasting and postprandial glucagon levels (pg/ml)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dimitrios Kehagias

Principal Investigator

University of Patras

研究点 (1)

Loading locations...

相似试验